Tevogen Bio to Receive $8M of Non-Dilutive Grant Funding, Reiterates Efficient Operations March 5, 2025
Tevogen Bio Strengthens Robust IP Portfolio With Filing of Predictive AI Patent, With the Goal to Establish a Blueprint to Unlock the Full Potential of T Cell Therapies and Accelerate AI Integration to Advance Its Bold Growth Agenda January 2, 2025
Tevogen Bio to Receive $8M of Non-Dilutive Grant Funding, Reiterates Efficient Operations March 5, 2025
Tevogen Bio Strengthens Robust IP Portfolio With Filing of Predictive AI Patent, With the Goal to Establish a Blueprint to Unlock the Full Potential of T Cell Therapies and Accelerate AI Integration to Advance Its Bold Growth Agenda January 2, 2025
